{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:59:06Z","timestamp":1780966746402,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1F1A1074801"],"award-info":[{"award-number":["NRF-2022R1F1A1074801"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seoul National University Bundang Hospital research fund","award":["02-2015-007"],"award-info":[{"award-number":["02-2015-007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47164-8","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:26:29Z","timestamp":1776421589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathologic implications of sphingosine-1-phosphate pathway in extranodal NK\/T-cell lymphoma according to immune subtype"],"prefix":"10.1038","volume":"16","author":[{"given":"Jin Ho","family":"Paik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyungjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-A","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"47164_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka, M., Harikumar, K. B., Milstien, S. & Spiegel, S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell. Biol. 22, 50\u201360. https:\/\/doi.org\/10.1016\/j.tcb.2011.09.003 (2012).","journal-title":"Trends Cell. Biol."},{"key":"47164_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-019-1014-8","volume":"19","author":"P Wang","year":"2019","unstructured":"Wang, P. et al. Roles of sphingosine-1-phosphate signaling in cancer. Cancer Cell Int. 19, 295. https:\/\/doi.org\/10.1186\/s12935-019-1014-8 (2019).","journal-title":"Cancer Cell Int."},{"key":"47164_CR3","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1084\/jem.20090525","volume":"206","author":"CN Jenne","year":"2009","unstructured":"Jenne, C. N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469\u20132481. https:\/\/doi.org\/10.1084\/jem.20090525 (2009).","journal-title":"J. Exp. Med."},{"key":"47164_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ni.3619","volume":"18","author":"V Fang","year":"2017","unstructured":"Fang, V. et al. Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-\u03b3 response. Nat. Immunol. 18, 15\u201325. https:\/\/doi.org\/10.1038\/ni.3619 (2017).","journal-title":"Nat. Immunol."},{"key":"47164_CR5","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio, R. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2 (2022).","journal-title":"Leukemia"},{"key":"47164_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13045-018-0687-0","volume":"11","author":"SJ Kim","year":"2018","unstructured":"Kim, S. J., Yoon, S. E. & Kim, W. S. Treatment of localized extranodal NK\/T cell lymphoma, nasal type: a systematic review. J. Hematol. Oncol. 11, 140. https:\/\/doi.org\/10.1186\/s13045-018-0687-0 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"47164_CR7","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1158\/1078-0432.Ccr-11-0494","volume":"17","author":"JH Paik","year":"2011","unstructured":"Paik, J. H. et al. MicroRNA-146a downregulates NF\u03baB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK\/T cell lymphoma. Clin. Cancer Res. 17, 4761\u20134771. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-11-0494 (2011).","journal-title":"Clin. Cancer Res."},{"key":"47164_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","volume":"10","author":"E Tse","year":"2017","unstructured":"Tse, E. & Kwong, Y. L. The diagnosis and management of NK\/T-cell lymphomas. J. Hematol. Oncol. 10, 85. https:\/\/doi.org\/10.1186\/s13045-017-0452-9 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"47164_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41379-019-0392-8","volume":"33","author":"J Cho","year":"2020","unstructured":"Cho, J. et al. Immune subtyping of extranodal NK\/T-cell lymphoma: a new biomarker and an immune shift during disease progression. Mod. Pathol. 33, 603\u2013615. https:\/\/doi.org\/10.1038\/s41379-019-0392-8 (2020).","journal-title":"Mod. Pathol."},{"key":"47164_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/s1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim, S. J. et al. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 17, 389\u2013400. https:\/\/doi.org\/10.1016\/s1470-2045(15)00533-1 (2016).","journal-title":"Lancet Oncol."},{"key":"47164_CR11","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569 (2016).","journal-title":"Blood"},{"key":"47164_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1186\/1471-2407-14-911","volume":"14","author":"JH Paik","year":"2014","unstructured":"Paik, J. H. et al. Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas. BMC Cancer. 14, 911. https:\/\/doi.org\/10.1186\/1471-2407-14-911 (2014).","journal-title":"BMC Cancer"},{"key":"47164_CR13","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1080\/10428194.2021.1894642","volume":"62","author":"Y Gao","year":"2021","unstructured":"Gao, Y. & Ding, X. miR-145-5p exerts anti-tumor effects in diffuse large B-cell lymphoma by regulating S1PR1\/STAT3\/AKT pathway. Leuk. Lymphoma. 62, 1884\u20131891. https:\/\/doi.org\/10.1080\/10428194.2021.1894642 (2021).","journal-title":"Leuk. Lymphoma"},{"key":"47164_CR14","doi-asserted-by":"publisher","first-page":"666387","DOI":"10.3389\/fcell.2021.666387","volume":"9","author":"M Yeon","year":"2021","unstructured":"Yeon, M. et al. The CAGE-MiR-181b-5p-S1PR1 Axis regulates anticancer drug resistance and autophagy in gastric cancer cells. Front. Cell. Dev. Biol. 9, 666387. https:\/\/doi.org\/10.3389\/fcell.2021.666387 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"47164_CR15","doi-asserted-by":"publisher","unstructured":"Zheng, Z. et al. Mir155 regulates osteogenesis and bone mass phenotype via targeting S1pr1 gene. Elife 12 https:\/\/doi.org\/10.7554\/eLife.77742 (2023).","DOI":"10.7554\/eLife.77742"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47164-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47164-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:15:39Z","timestamp":1780964139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47164-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47164"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47164-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the institutional review board of the Seoul National University Bundang Hospital (B-2208-774-302). Our research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived because this study included only retrospective observational data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"17822"}}